Phase 3 Study of Sacituzumab Govitecan vs Physician's Choice in Subjects With Hormonal Receptor-Positive Human Epidermal Growth Factor Receptor 2 Negative Metastatic Breast Cancer Who Have Failed at Least 2 Prior Chemotherapy Regimens
- Niravath, Polly A. (PI)
- Abdelrahim, Maen (Key Personnel)
- Bernicker, Eric H. (Key Personnel)
- Chang, Jenny C. (Key Personnel)
- Darcourt, Jorge (Key Personnel)
- Heyne, Kirk (Key Personnel)
- Singh, Monisha (Key Personnel)
- Zhang, Jun (Key Personnel)
Project: Clinical Trial